DK0455475T3 - Anvendelse af triclosan ved behandlingen af sygdomme i mavetarmkanalen - Google Patents

Anvendelse af triclosan ved behandlingen af sygdomme i mavetarmkanalen

Info

Publication number
DK0455475T3
DK0455475T3 DK91303929.3T DK91303929T DK0455475T3 DK 0455475 T3 DK0455475 T3 DK 0455475T3 DK 91303929 T DK91303929 T DK 91303929T DK 0455475 T3 DK0455475 T3 DK 0455475T3
Authority
DK
Denmark
Prior art keywords
triclosan
medicaments
treatment
gastrointestinal disorders
spheroids
Prior art date
Application number
DK91303929.3T
Other languages
Danish (da)
English (en)
Inventor
Peter William Dettmar
John Gareth Lloyd-Jones
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Application granted granted Critical
Publication of DK0455475T3 publication Critical patent/DK0455475T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91303929.3T 1990-05-03 1991-05-01 Anvendelse af triclosan ved behandlingen af sygdomme i mavetarmkanalen DK0455475T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010039A GB9010039D0 (en) 1990-05-03 1990-05-03 Medicament preparation

Publications (1)

Publication Number Publication Date
DK0455475T3 true DK0455475T3 (da) 1995-10-30

Family

ID=10675466

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91303929.3T DK0455475T3 (da) 1990-05-03 1991-05-01 Anvendelse af triclosan ved behandlingen af sygdomme i mavetarmkanalen

Country Status (12)

Country Link
US (1) US5286492A (de)
EP (1) EP0455475B1 (de)
AT (1) ATE124626T1 (de)
AU (1) AU645555B2 (de)
CA (1) CA2041400C (de)
DE (1) DE69110969T2 (de)
DK (1) DK0455475T3 (de)
GB (2) GB9010039D0 (de)
HK (1) HK1007963A1 (de)
IE (1) IE65826B1 (de)
NZ (1) NZ237904A (de)
ZA (1) ZA912933B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440395B1 (en) 1992-06-22 2002-08-27 Barry M. Libin Antiplaque mouth rinse
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
EP0697861B1 (de) * 1993-05-13 1998-08-26 Unilever N.V. Orale zusammensetzungen, die triclosan enthalten, zur behandlung von aphthen
AU7833194A (en) * 1993-09-20 1995-04-10 Procter & Gamble Company, The Use of triclosan phosphates for the treatment of gastrointestinal disorders due to heliobacter infection
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
AU6580494A (en) * 1994-05-11 1995-12-05 P.N. Gerolymatos S.A. Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
US5498528A (en) * 1994-06-10 1996-03-12 King; Wing Detection of helicobacter pylori
WO1996000569A1 (en) * 1994-06-29 1996-01-11 Reckitt & Colman Products Limited Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta
GB9505032D0 (en) 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
US5389386A (en) * 1994-06-30 1995-02-14 Church & Dwight Co., Inc. Method of controlling fungal disease in cultivated plants
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
CA2292546A1 (en) * 1996-05-31 1997-12-04 R & D Ventures, Inc. Effervescent bath tablet compositions
DE69706566T2 (de) * 1996-08-13 2002-07-11 P.N. Gerolymatos S.A., Kruoneri Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
GB9708772D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
JP2001522368A (ja) * 1997-04-30 2001-11-13 レキット アンド コールマン プロダクツ リミテッド 流動性アルギン酸塩組成物
US6108850A (en) * 1997-06-03 2000-08-29 Mclaughlin; Gerald Accelerated method and instrumentation for whitening teeth
US5980914A (en) * 1997-08-22 1999-11-09 P.N. Gerolymatos S.A. Clioquinol for the treatment of Parkinson's disease
US5994323A (en) * 1997-12-31 1999-11-30 P.N. Gerolymatos S.A. Pharmaceutical compositions comprising clioquinol in combination with vitamin B12 and therapeutic and prophylactic uses thereof
GB9809347D0 (en) * 1998-05-05 1998-07-01 Reckitt & Colmann Prod Ltd Compositions
SI0976395T1 (sl) * 1998-07-30 2006-04-30 Merck Sante Sas Tableta s podaljsanim sproscanjem zdravilne ucinkovine v zelodcu
US5945089A (en) * 1998-11-05 1999-08-31 I-Dent International Corporation Method of treating mucositis
IN190017B (de) * 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
KR100753471B1 (ko) * 2001-09-06 2007-08-31 주식회사 엘지생활건강 트리클로산을 포함하는 마이크로 캡슐의 제조방법
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
KR20040089628A (ko) * 2002-03-04 2004-10-21 가부시키가이샤 메드렉스 생체내에서 상전이하는 액상 매트릭스 및 액상 경구 제제
JP2006527700A (ja) * 2003-06-18 2006-12-07 ナムローゼ フェンノートシャップ ニュートリシア 熱い液体繊維製品
MXPA06000417A (es) * 2003-07-10 2006-03-17 Smithkline Beecham Corp Composiciones farmaceuticas.
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
EP1931222B1 (de) * 2005-10-05 2012-02-15 FMC Biopolymer AS Gelierungszusammensetzungen und -verfahren
DE102006062111A1 (de) 2006-12-23 2008-06-26 Farco-Pharma Gmbh Zusammensetzung, insbesondere für das Blockieren von Kathetern
JP7518162B2 (ja) * 2019-10-31 2024-07-17 ザ プロクター アンド ギャンブル カンパニー 抗菌粒子

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH406127A (de) * 1963-02-22 1966-08-15 Geigy Ag J R Verfahren zum antimikrobiellen Ausrüsten von Textilien
JPS5157813A (en) * 1974-11-14 1976-05-20 Sankyo Co Ll dooba mataha sonojudotaiseizaino seiho
GB2015875B (en) * 1978-02-24 1982-10-20 Novex Foreign Trade Co Ltd Solid oral pharaceutical product with increased efficacy and predetermined steady state of solubility
EP0222834A4 (de) * 1985-04-18 1989-10-04 Borody Thomas J Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
EP0206625B1 (de) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Zusammensetzungen zur Behandlung von Magen-Darmstörungen
DE3686362T2 (de) * 1985-06-13 1993-02-11 Marshall Barry James Verfahren zur behandlung von magen-darmstoerungen.
GB8526093D0 (en) * 1985-10-22 1985-11-27 Beecham Group Plc Composition
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders

Also Published As

Publication number Publication date
AU7596891A (en) 1991-11-07
IE65826B1 (en) 1995-11-15
NZ237904A (en) 1993-06-25
EP0455475A3 (en) 1992-02-26
CA2041400A1 (en) 1991-11-04
DE69110969D1 (de) 1995-08-10
EP0455475B1 (de) 1995-07-05
AU645555B2 (en) 1994-01-20
GB2243549A (en) 1991-11-06
CA2041400C (en) 2001-04-24
US5286492A (en) 1994-02-15
GB9010039D0 (en) 1990-06-27
GB9109439D0 (en) 1991-06-26
GB2243549B (en) 1994-05-04
IE911483A1 (en) 1991-11-06
DE69110969T2 (de) 1995-11-16
EP0455475A2 (de) 1991-11-06
ATE124626T1 (de) 1995-07-15
ZA912933B (en) 1992-01-29
HK1007963A1 (en) 1999-04-30

Similar Documents

Publication Publication Date Title
AU645555B2 (en) Improvements in or relating to the treatment of gastrointestinal disorders
DE3766343D1 (de) Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
PL341466A1 (en) Instantaneously spreading dised pharmacological preparation and method of forming granules
WO1999059544A3 (en) Orally disintegrable tablets
NO2011009I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
ZA828639B (en) Novel triazoloquinazolinones, their preparation and pharmaceutical formulations containing these compounds
ZA793843B (en) New imidazoquinoxalines and their salts,process for their preparation,their use as medicaments and the pharmaceutical compositions containing them
JPS5781409A (en) External plaster
ATE77049T1 (de) Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe.
DE2960927D1 (en) N1-benzoyl-n2-phenyl-1,3-diaminopropane-2-ols and their salts, process for their preparation and medicaments containing them
JPS5420127A (en) Solid nifedipine preparaton
JPS5498339A (en) Carcinostatic agent
JPS5759808A (en) Remedy and preventive for digestive ulcer
JPS5352617A (en) Solid drug coating composition
JPS5517329A (en) Remedy for dementia and dotage
JPS57114518A (en) Hypotensive agent
RU96123569A (ru) Лекарственный препарат
DE69325531D1 (de) Oral anzuwendendes Arzneimittel bestehend aus Ibuprofen
JPS5634624A (en) Central nervous system depressant
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives
JPS57114519A (en) Antiarteriosclerotic agent
JPS57144216A (en) Antiulcer